CRP and immunoglobulin G4-related sclerosing disease: Our findings are consistent with prior studies demonstrating that conventional biomarkers of disease activity, ESR, CRP, and serum IgG4 levels, do not appear to correlate with the metabolic activity of IgG4-RD lesions, with conventional biomarkers showing conflicting results as a measure of disease and response to treatment.